Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVRS Corindus Vascular Robotics	$4.27	$4.27	$0.78 ▼ $4.40	$891.09M	N/A	1.99 million shs	N/A
INMD InMode	$14.82 +1.7%	$14.31	$13.14 ▼ $19.85	$936.46M	1.93	1.26 million shs	444,577 shs
IRMD iRadimed	$72.39 +1.2%	$62.65	$44.58 ▼ $73.47	$920.74M	0.94	45,020 shs	25,961 shs
STXS Stereotaxis	$2.79 +0.9%	$2.37	$1.54 ▼ $3.05	$252.46M	1.51	453,977 shs	245,822 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVRS Corindus Vascular Robotics	0.00%	0.00%	0.00%	0.00%	0.00%
INMD InMode	-1.62%	+1.82%	-1.02%	+0.21%	-10.34%
IRMD iRadimed	-1.60%	+1.98%	+26.95%	+36.06%	+55.98%
STXS Stereotaxis	-4.17%	-0.72%	+22.67%	+29.58%	+20.52%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CVRS Corindus Vascular Robotics	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
INMD InMode	2.1198 of 5 stars	2.1	2.0	0.0	0.0	3.1	1.7	1.9
IRMD iRadimed	4.5607 of 5 stars	1.5	4.0	1.7	4.4	3.2	4.2	1.9
STXS Stereotaxis	0.1583 of 5 stars	0.0	1.0	0.0	0.0	0.6	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CVRS Corindus Vascular Robotics	0.00	N/A	N/A	N/A
INMD InMode	2.13	Hold	$18.04	21.78% Upside
IRMD iRadimed	3.00	Buy	$72.00	-0.53% Downside
STXS Stereotaxis	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest STXS, INMD, CVRS, and IRMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/30/2025	INMD InMode	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
7/30/2025	INMD InMode	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$24.00 ➝ $21.00
7/11/2025	INMD InMode	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold	$15.00

(Data available from 8/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CVRS Corindus Vascular Robotics	N/A	N/A	N/A	N/A	N/A	N/A
INMD InMode	$394.82M	2.37	$1.82 per share	8.12	$10.12 per share	1.46
IRMD iRadimed	$73.24M	12.57	$1.58 per share	45.92	$6.85 per share	10.57
STXS Stereotaxis	$26.92M	9.38	N/A	N/A	$0.07 per share	39.79

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CVRS Corindus Vascular Robotics	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
INMD InMode	$181.27M	$2.47	6.00	8.14	N/A	44.50%	18.38%	16.35%	10/29/2025 (Estimated)
IRMD iRadimed	$19.23M	$1.62	44.68	36.19	N/A	26.61%	23.30%	20.62%	10/30/2025 (Estimated)
STXS Stereotaxis	-$24.05M	-$0.28	N/A	N/A	N/A	-73.43%	-440.00%	-50.62%	11/10/2025 (Estimated)

Latest STXS, INMD, CVRS, and IRMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
7/30/2025	Q2 2025	INMD InMode	$0.50	$0.47	-$0.03	$0.42	$98.45 million	$95.60 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CVRS Corindus Vascular Robotics	N/A	N/A	N/A	N/A	N/A
INMD InMode	N/A	N/A	N/A	N/A	N/A
IRMD iRadimed	$0.68	0.94%	N/A	41.98%	1 Years
STXS Stereotaxis	N/A	N/A	N/A	N/A	N/A

Latest STXS, INMD, CVRS, and IRMD Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/31/2025	IRMD iRadimed	quarterly	$0.17	1.13%	8/18/2025	8/18/2025	8/28/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CVRS Corindus Vascular Robotics	N/A	N/A	N/A
INMD InMode	N/A	9.60	8.58
IRMD iRadimed	N/A	8.78	7.51
STXS Stereotaxis	N/A	1.06	0.59

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CVRS Corindus Vascular Robotics	N/A
INMD InMode	68.04%
IRMD iRadimed	92.34%
STXS Stereotaxis	45.35%

Insider Ownership

Company	Insider Ownership
CVRS Corindus Vascular Robotics	N/A
INMD InMode	6.92%
IRMD iRadimed	36.80%
STXS Stereotaxis	17.77%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CVRS Corindus Vascular Robotics	90	208.69 million	N/A	Not Optionable
INMD InMode	480	63.21 million	58.84 million	Optionable
IRMD iRadimed	110	12.72 million	8.04 million	Optionable
STXS Stereotaxis	130	90.65 million	74.55 million	Not Optionable

STXS, INMD, CVRS, and IRMD Headlines

Recent News About These Companies

Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript

August 8, 2025 | seekingalpha.com

Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates

August 7, 2025 | zacks.com

Stereotaxis Reports 2025 Second Quarter Financial Results

August 7, 2025 | globenewswire.com

Warberg Asset Management LLC Acquires 275,784 Shares of Stereotaxis Inc. (NYSEAMERICAN:STXS)

August 4, 2025 | marketbeat.com

Will Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should Know

July 31, 2025 | zacks.com

Stereotaxis (STXS) to Release Earnings on Thursday

July 31, 2025 | marketbeat.com

Stereotaxis (STXS) Gets a Buy from TD Cowen

July 30, 2025 | theglobeandmail.com

Essex Investment Management Co. LLC Buys 343,130 Shares of Stereotaxis Inc. (NYSEAMERICAN:STXS)

July 29, 2025 | marketbeat.com

Stereotaxis, Inc.: Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

July 28, 2025 | finanznachrichten.de

Stereotaxis Wins FDA Nod for Catheter

July 28, 2025 | baystreet.ca

Stereotaxis stock soars after FDA clearance for robotic mapping catheter

July 28, 2025 | za.investing.com

Stereotaxis gets FDA green light for robotic electrophysiology mapping catheter

July 28, 2025 | massdevice.com

Stereotaxis shares jump after FDA approves robotic mapping catheter

July 28, 2025 | msn.com

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

July 28, 2025 | globenewswire.com

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

July 23, 2025 | globenewswire.com

Stereotaxis announces $12.5M offering

July 18, 2025 | massdevice.com

Stereotaxis Sinks on Common Stock Offering

July 17, 2025 | baystreet.ca

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

July 17, 2025 | globenewswire.com

Stereotaxis, Inc. (STXS) - Yahoo Finance

July 10, 2025 | finance.yahoo.com

Stereotaxis Publishes Positive Results from MAGiC Catheter Study

July 10, 2025 | msn.com

Stereotaxis Reports Positive Initial Data From MAGiC Catheter Trial - Yahoo Finance

July 8, 2025 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

STXS, INMD, CVRS, and IRMD Company Descriptions

Corindus Vascular Robotics NYSEAMERICAN:CVRS

$4.27 0.00 (0.00%)

As of 11/27/2019

Corindus Vascular Robotics, Inc. designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures. Its CorPath system allows the physician to perform procedures with a control console located within an interventional cockpit; and CorPath GRX system enables the precise robotic-assisted control of guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit. The company sells its products through direct sales force, as well as through distributor and partnership relationships. It serves vascular, coronary, peripheral vascular, neurointerventional, and structural heart markets. Corindus Vascular Robotics, Inc. is headquartered in Waltham, Massachusetts.

InMode NASDAQ:INMD

$14.82 +0.25 (+1.68%)

As of 03:43 PM Eastern

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

iRadimed NASDAQ:IRMD

$72.39 +0.89 (+1.24%)

As of 03:43 PM Eastern

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Stereotaxis NYSEAMERICAN:STXS

$2.78 +0.03 (+0.91%)

As of 03:42 PM Eastern

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time